Developing appropriate strategies to sustain optimal medication adherence among the increasing number of HIV-positive patients taking antiretroviral therapy (ART) in sub-Saharan Africa is a major challenge. The objective of this study was to determine patient, regimen, disease, patient-provider, and healthcare-related factors associated with adherence with ART over a one-year period, and assess the impact of adherence on treatment outcomes. We performed a prospective, observational study among 246 patients who were initiated on ART in Ethiopia. Of 172 who completed follow-up, 130 (75.6%) had ≥95% adherence. In the multivariate analyses, a higher baseline BMI (OR, 1.2; 95% CI 1.0, 1.4) and use of reminder devices (OR, 9.1; 95% CI 2.0, 41.6) remained positively associated with adherence, while a higher HIV symptom and adverse drug reaction distress score was an independent negative predictor of adherence (OR, 0.90; 95% CI 0.9, 1.0) CD4 count increase was significantly higher in the adherent patients compared to nonadherent patients at 12 months (159 cells/µL [interquartile range (IQR), 72-324 cells/µL] vs. 132 cells/µL [IQR,; p = 0.026). Our findings indicate that interventions aimed at improving adherence and thereby treatment outcomes in patients initiated on ART should promote the use of reminder devices, and monitor HIV symptoms and adverse reaction distress and nutritional status.
Introduction
Near perfect adherence (≥95%) to antiretroviral therapy (ART) is required to achieve better virological and treatment outcomes (Nachega et al., 2012) . Previous studies have identified regimen-related factors, disease-related factors, healthcare-related factors, psychological factors, and knowledge and belief about treatments as being associated with non-adherence (Ammassari et al., 2002; Langebeek et al., 2014) . In the past decade, ART services scale-up has occurred in Ethiopia and by the end of 2012 a total 270,460 adult patients were receiving ART (Ethiopian Federal Ministry of Health HIV/AIDS Prevention and Control Office, 2014). However, achievement of optimal medication adherence (≥95%) is becoming the greatest challenge in the management of HIV/AIDS (Beyene, Gedif, Gebre-Mariam, & Engidawork, 2009) . The available studies in Ethiopia are limited in that they have only assessed limited variables at a single point in time (Amberbir, Woldemichael, Getachew, Girma, & Deribe, 2008; Beyene et al., 2009; Tadios & Davey, 2006; Tiyou, Belachew, Alemseged, & Biadgilign, 2010) . The objective of this study was to identify key determinants of adherence with ART over a one-year period, and to compare treatment outcomes between adherent and non-adherent patients.
Methods
This was a prospective cohort study of treatment-naïve adult (≥18 years) patients with HIV/AIDS recruited from Felege Hiwot and Gondar University Hospitals, northwest Ethiopia, from December 2012 through March 2013. Details of the study setting have been described elsewhere (Bezabhe, Peterson, Bereznicki, Chalmers, & Gee, 2013) . Written informed consent was obtained from each participant. Patients were followed for 12 months after initiation of ART. All patients who attended 12 months' follow-up and had complete self-reported adherence data were included in this analysis.
Measures
Details of the questionnaires and the time-line of administration have previously been described (Bezabhe et al., 2013) . Patients' sociodemographic and socioeconomic information was self-reported at the study baseline. Clinical data were obtained from patients' medical charts every month for the first six months and every three months thereafter, in line with patients' appointment schedules in the ART clinics. Dose and time adherence was measured using the modified AIDS Clinical Trial Group (ACTG) selfreported adherence questionnaire (Chesney et al., 2000) . HIV clinic-based pill count, 30-day visual analogue scale (VAS), and medication possession ratio measures were also carried out at the same time for comparison. Adherence assessment in this study was the combined self-reported dose and time adherence based on ACTG. Optimal adherence in this study was defined as achieving 95% or more at 12 months.
The reliability of scales using 
Statistical analysis
Characteristics of adherent versus non-adherent patients were compared using independent sample t-tests for normally distributed continuous variables; Mann-Whitney U tests for ordinal and non-normally distributed continuous variables; and chi-square tests for nominal variables. Variables with a p value of ≤0.2 on univariate analysis were included in the logistic regression model. p < .05 was used as the threshold of statistical significance. Analyses were performed using SPSS, version 22 (IBM Corp., New York, USA).
Results

Study participants
From December 2012 to March 2013, 347 HIV-positive individuals were screened; 337 adults (≥18 years; 191 females) were initiated on ART and 246 (72.9%) patients (143 females) were enrolled in this study. One hundred and seventy-two participants who completed 12 months' follow-up were included in this analysis. Seventy-four were excluded from analysis: 15 were lost to follow-up, 17 withdrew from the study, 15 died, 12 transferred to other ART clinics, and 15 did not complete 12 months' follow-up. There were no significant differences in gender, age, CD4 count, and weight at baseline between those who did and did not participate in the study and between those who did and did not complete 12 months' follow-up. Patients who had WHO clinical stage III/IV HIV/AIDS at baseline were more likely to not complete 12 months' follow-up. At the enrolment visit, 136 (79%) patients had their own mobile phone and of those 87 (64%) patients were able to send and receive a text-message. The baseline characteristics of study participants who completed the study are as shown in Tables 1 and 2 .
Patterns of adherence over time and predictors
The proportion of non-adherent patients increased over the study period by 4.1% and 18.4% from months 3 to 12 for ACTG self-reported and VAS assessments, respectively (Figure 1 ). The decline in mean VAS adherence was statistically significantly over the study period (p ≤ .05). Based on ACTG self-reported adherence, 130 patients (75.6%) reported optimal adherence (≥95%) at 12 months. Twelve-month adherence measurements were used in the analysis as long-term adherence is important in HIV/AIDS. The closest measured value of the variables to the 12-month time point was used in the analysis. In the multivariate analyses, a higher baseline BMI (OR, 1.2; 95% CI 1.0, 1.4) and use of reminder devices (OR, 9.1; 95% CI 2.0, 41.6) remained positively associated with adherence, while a higher HIV symptom and adverse drug reaction (ADR) distress score was an independent negative predictor of adherence (OR, 0.90; 95% CI 0.9, 1.0) (Tables 1 and 2 ).
Treatment outcomes
Among all patients, CD4 count increased from baseline by a median of 146 cells/µL at month 12. The CD4 count increase was significantly higher in the adherent patients compared to non-adherent patients (159 cells/ 
Discussion
This is the first prospective study to assess the association between adherence and a range of patient-related variables in adult patients who were initiated on ART in Ethiopia. The VAS adherence measure better identified non-adherent patients in this study; thus there may be advantage to clinicians and researchers in resource-limited settings using VAS over other measures. Adherence was independently associated with higher BMI, lower HIV symptom and ADR distress, and use of reminder devices. We believe that these findings have important implications for improving services and interventions for patients taking ART in Ethiopia following the remarkable scale-up over the past decade.
We demonstrated that higher HIV symptom and ADR distress scores were independently associated with non-adherence to ART. To our knowledge, this is the first study to demonstrate this relationship. Symptoms attributed to HIV infection and/or ADRs of ART are an important source of distress (Gonzalez, Zvolensky, Parent, Grover, & Hickey, 2012) . Previous studies have mainly focused on non-specific perceived distress in HIV patients and reported inconsistent findings on the role of distress on treatment outcomes (Chesney et al., 2000; Ironson et al., 1994) . Some studies have demonstrated that distress predicted non-adherence to ART Ironson et al., 1994) , CD4 count decline (Remor, Penedo, Shen, & Schneiderman, 2007) , and virologic failure (Mugavero et al., 2009 ). Distress precipitates negative health behaviour (Remor et al., 2007) that may impair patients from achieving optimal adherence to ART. Given our findings regarding the association between adherence and increase in CD4 count, distress associated with HIV symptoms and ADRs has important implications for treatment outcomes. Thus, routine monitoring for HIV symptoms and ADRs are needed in Ethiopian patients initiated on ART to improve adherence and thereby patient outcomes.
Use of medication reminder devices was positively associated with adherence to ART in this study. Mobile phone ownership has grown dramatically in sub-Saharan Africa, including Ethiopia (International Telecommunications Union, 2014). In our study, almost four out of five patients possessed a mobile phone, of whom more than 64% were able to send and receive a text-message reminder. A randomised controlled trial in Kenya (Lester et al., 2010; Pop-Eleches et al., 2011) reported that shortmessage services improved adherence to ART. Other reminder devices such as clock and watch alarms could also help patients taking long-term medication such as ART in resource-limited settings. Clinics should propose programmes that teach patients how to use mobile phones and other reminder devices to promote adherence to ART and thereby treatment outcomes.
Strengths of this study include the prospective design with previously validated questionnaires that enabled us to determine factors associated with long-term nonadherence to ART, and the fact that a wide range of factors were evaluated. Its prospective nature also allowed assessment of changing adherence levels over time. These data do have several limitations, however. We used self-reported adherence measures for our data analyses although objective measures are believed to be more precise in comparative studies (Arnsten et al., 2001; Liu et al., 2001; White et al., 2015) .
Conclusion
This study found that higher BMI, lower HIV symptom and ADRs distress scores, and use of reminder devices were independent predictors of adherence. Implementation of measures to consistently monitor HIV symptoms and ADRs distress and malnutrition, and to promote the use of reminder devices may improve adherence and treatment outcomes in patients initiated on ART.
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